Individuals across the globe have an opportunity to make a direct contribution into the fight against Malaria which while curable continues to maim multitudes across the African continent.
This is thanks to the launch of an online based Power of One campaign put together by pharmaceutical company, Novartis, and nongovernmental organization, Malaria No More. Launched last week, the campaign encourages people around the world to help end child deaths from malaria through donation into the funding of treatment. The initiative hops into the rising wave pooling ordinary people into collective social action as enabled by the power of digital media.
Harnessing social, mobile, and e-commerce technologies, Power of One enables the public to purchase a treatment and track the journey of a treatment. Donors will be able to see the effect of their donation on the ground, share information with their networks and recruit other donors.
Zambia will be the first country to receive deliveries of treatments and tests as a result of the Power of One campaign.
In launching the campaign the organisations noted that Malaria is a preventable and treatable disease costing a dollar a day, but it still kills a child every minute. It is estimated that 436 million additional treatments will be needed to treat malaria patients across Africa between now and the end of 2015.
The Power of One campaign aims to address this treatment gap through direct donations and existing government commitments. Every dollar donated to the campaign will buy and deliver a treatment to a child diagnosed with malaria.
Novartis will support the campaign financially and donate up to three million Coartem Dispersible treatments to match antimalarials funded by the public.
Joseph Jimenez, CEO of Novartis, said “I am proud of the significant and longstanding commitment Novartis has to the fight against malaria. For all our progress though, there’s still more work to do”. “We need more help to close the treatment gap and Power of One offers everyone a chance to engage and make a difference for children suffering from malaria.”
Martin Edlund, CEO, Malaria No More, said “It’s unacceptable that a child dies every minute for lack of a dollar’s worth of treatment,”. “We’re urging the world to join the Power of One campaign and to donate and engage their friends in this fight.”
Novartis is the exclusive treatment sponsor of the Power of One campaign, joining some of the world’s most innovative companies. Additional sponsors include Alere, which will provide malaria rapid diagnostic tests, 21st Century Fox, AHAlife.com, Causes.com, Time Warner, Twitter, Venmo and others.
David Reddy, CEO of Medicines for Malaria Venture applauded the campaign. “MMV applauds Novartis on this laudable achievement”.
“Novartis has done a tremendous job of bringing an innovative drug to the vulnerable young victims of malaria in Zambia and over 50 other countries, giving it global reach. We at MMV are proud to have partnered with Novartis on the development of this important formulation.”